These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32474331)

  • 1. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
    Taboada M; Caruezo V; Naveira A; Atanassoff PG
    J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
    Cadegiani FA
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
    [No Abstract]   [Full Text] [Related]  

  • 4. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
    Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
    Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rationale for targeting the P2X7 receptor in Coronavirus disease 19.
    Di Virgilio F; Tang Y; Sarti AC; Rossato M
    Br J Pharmacol; 2020 Nov; 177(21):4990-4994. PubMed ID: 32441783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
    Courcelle R; Gaudry S; Serck N; Blonz G; Lascarrou JB; Grimaldi D;
    Crit Care; 2020 Jul; 24(1):446. PubMed ID: 32684169
    [No Abstract]   [Full Text] [Related]  

  • 8. Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic.
    Prescott HC; Rice TW
    JAMA; 2020 Oct; 324(13):1292-1295. PubMed ID: 32876693
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
    Nicolau DV; Bafadhel M
    Lancet Respir Med; 2020 Sep; 8(9):846-847. PubMed ID: 32738928
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
    Savioli F; Rocha L; Góis A; Nakano LC
    J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
    [No Abstract]   [Full Text] [Related]  

  • 11. The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
    Kloc M; Ghobrial RM
    Mult Scler Relat Disord; 2020 Oct; 45():102437. PubMed ID: 32763844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome.
    Tamimi F; Abusamak M; Akkanti B; Chen Z; Yoo SH; Karmouty-Quintana H
    Br J Pharmacol; 2020 Nov; 177(21):4845-4850. PubMed ID: 32442317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
    Verrall GM
    Front Immunol; 2020; 11():2167. PubMed ID: 33013911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.
    Halpin DMG; Singh D; Hadfield RM
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32341100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
    Choudhury R; Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Talmor DS; Nydam TL; Yaffe MB
    World J Emerg Surg; 2020 Apr; 15(1):29. PubMed ID: 32312290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
    [No Abstract]   [Full Text] [Related]  

  • 17. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
    Caocci G; La Nasa G
    Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
    Mohamed MMA; El-Shimy IA; Hadi MA
    Crit Care; 2020 Jun; 24(1):311. PubMed ID: 32513225
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome.
    Caracciolo M; Macheda S; Labate D; Tescione M; La Scala S; Vadalà E; Squillaci R; D'Aleo F; Morabito A; Garreffa C; Marciano MC; Oliva EN
    Front Immunol; 2020; 11():1942. PubMed ID: 32983123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.